Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

NCT: NCT07422675 · RECRUITING

NCT IDNCT07422675
StatusRECRUITING
Start Date2026-02-01
Completion2027-01-31
SponsorSerina Therapeutics (INDUSTRY)
First posted
Last updated

Brief Summary

This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑